home / stock / iccc / iccc news


ICCC News and Press, ImmuCell Corporation From 08/15/25

Stock Information

Company Name: ImmuCell Corporation
Stock Symbol: ICCC
Market: NASDAQ
Website: immucell.com

Menu

ICCC ICCC Quote ICCC Short ICCC News ICCC Articles ICCC Message Board
Get ICCC Alerts

News, Short Squeeze, Breakout and More Instantly...

ICCC - ImmuCell outlines cautious H2 outlook as capacity expansion supports First Defense suite

2025-08-15 11:04:43 ET More on ImmuCell ImmuCell Corporation (ICCC) Q2 2025 Earnings Call Transcript Financial information for ImmuCell Read the full article on Seeking Alpha For further details see: ImmuCell outlines cautious H2 outlook as capacity expan...

ICCC - ImmuCell GAAP EPS of $0.06, revenue of $6.4M

2025-08-14 16:23:29 ET More on ImmuCell Financial information for ImmuCell Read the full article on Seeking Alpha For further details see: ImmuCell GAAP EPS of $0.06, revenue of $6.4M

ICCC - ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025

PORTLAND, Maine, Aug. 14, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health a...

ICCC - Expected US Company Earnings on Thursday, August 14th, 2025

Century Therapeutics Inc. (IPSC) is expected to report $-0.38 for Q2 2025 Birchtech Corp Com (BCHT) is expected to report for Q2 2025 Cellectar Biosciences Inc. (CLRB) is expected to report $-3.6 for Q2 2025 Acuren Corporation (TIC) is expected to report for quarter end 2025-06-30 ...

ICCC - Expected earnings - ImmuCell Corporation

ImmuCell Corporation (ICCC) is expected to report for Q2 2025

ICCC - ImmuCell Announces Bank Debt Refinancing

PORTLAND, Maine, Aug. 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health a...

ICCC - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025

PORTLAND, Maine, Aug. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health a...

ICCC - (ICCC) Trading Signals

2025-07-12 01:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

ICCC - ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025

PORTLAND, Maine, July 09, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health a...

ICCC - ImmuCell initiates CEO succession search ahead of planned 2026 retirement

2025-06-25 08:53:38 ET More on ImmuCell ImmuCell Corporation (ICCC) Q1 2025 Earnings Call Transcript ImmuCell signals capacity expansion to $30M+ and launches new First Defense formats as backlog declines Financial information for ImmuCell Read the full art...

Previous 10 Next 10